Literature DB >> 8266623

Clinical signs and lesions in gnotobiotic pigs inoculated with Shiga-like toxin I from Escherichia coli.

S A Dykstra1, R A Moxley, B H Janke, E A Nelson, D H Francis.   

Abstract

Gnotobiotic pigs were used as a model to study the contribution of Shiga-like toxin I to natural disease caused by enterohemorrhagic Escherichia coli in calves and human beings. Eleven 2- to 7-day-old gnotobiotic pigs of either sex, obtained by closed hysterotomy, were injected intramuscularly with graded doses of partially purified Shiga-like toxin I derived from a lysogenized Escherichia coli strain. Four other gnotobiotic pigs were injected with a mock toxin preparation obtained from a nonlysogenized culture of the same E. coli strain. All toxin-injected pigs developed diarrhea, and three displayed signs of neurologic disease. Pigs either died or were euthanatized 2 to 4 days post-inoculation. Necrosis of muscle was grossly evident at the site of injection in all toxin-inoculated pigs. Hemorrhage in the lumen of the small and large intestines and blood in the feces were also evident in two toxin-inoculated pigs. Microscopically, severe necrotizing myositis at the injection site, multifocal encephalomalacia, and mucosal infarcts and hemorrhage in the small and large intestines were seen. In small vessels at lesion sites, endothelial cells were frequently swollen or necrotic. Pigs inoculated with mock toxin did not develop diarrhea or exhibit signs of neurologic disease, and the only apparent lesion was mild microscopic myositis at the injection site in 1/4 pigs. The results of this study indicate that Shiga-like toxin I causes vascular damage and ischemic necrosis in the intestines and brains of gnotobiotic pigs. These lesions are similar to those seen in the intestines of calves and human beings with hemorrhagic colitis and in the brains of human beings with thrombotic thrombocytopenic purpura.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8266623     DOI: 10.1177/030098589303000502

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  9 in total

1.  Comparison of the expressed porcine Vbeta and Jbeta repertoire of thymocytes and peripheral T cells.

Authors:  John E Butler; Nancy Wertz; Jishan Sun; Randy E Sacco
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

2.  Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1.

Authors:  F B Taylor; V L Tesh; L DeBault; A Li; A C Chang; S D Kosanke; T J Pysher; R L Siegler
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

3.  Escherichia coli O157:H7 causes more-severe systemic disease in suckling piglets than in colostrum-deprived neonatal piglets.

Authors:  E A Dean-Nystrom; J F Pohlenz; H W Moon; A D O'Brien
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

4.  Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells.

Authors:  M L McKee; A R Melton-Celsa; R A Moxley; D H Francis; A D O'Brien
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.

Authors:  Diane R Baker; Rodney A Moxley; Mike B Steele; Jeffrey T Lejeune; Jane Christopher-Hennings; Ding-Geng Chen; Philip R Hardwidge; David H Francis
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

6.  Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin.

Authors:  Shantini D Gamage; Jane E Strasser; Claudia L Chalk; Alison A Weiss
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model.

Authors:  Rodney A Moxley; David H Francis; Mizuho Tamura; David B Marx; Kristina Santiago-Mateo; Mojun Zhao
Journal:  Toxins (Basel)       Date:  2017-01-26       Impact factor: 4.546

8.  Modeling Hemolytic-Uremic Syndrome: In-Depth Characterization of Distinct Murine Models Reflecting Different Features of Human Disease.

Authors:  Sophie Dennhardt; Wiebke Pirschel; Bianka Wissuwa; Christoph Daniel; Florian Gunzer; Sandro Lindig; Anna Medyukhina; Michael Kiehntopf; Wolfram W Rudolph; Peter F Zipfel; Matthias Gunzer; Marc Thilo Figge; Kerstin Amann; Sina M Coldewey
Journal:  Front Immunol       Date:  2018-06-25       Impact factor: 7.561

Review 9.  The piglet as a model for B cell and immune system development.

Authors:  J E Butler; K M Lager; I Splichal; D Francis; I Kacskovics; M Sinkora; N Wertz; J Sun; Y Zhao; W R Brown; R DeWald; S Dierks; S Muyldermans; J K Lunney; P B McCray; C S Rogers; M J Welsh; P Navarro; F Klobasa; F Habe; J Ramsoondar
Journal:  Vet Immunol Immunopathol       Date:  2008-11-01       Impact factor: 2.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.